Info

Barr Pharmaceuticals, Inc. (Barr) is a holding company. Through its subsidiaries, the Company operates as a global specialty pharmaceutical company with operations in more than 30 countries. Through its principal subsidiaries, Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. (Duramed) and PLIVA d.d. (PLIVA), the Company is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals. Barr is also involved in the development of generic biologic products. The Company operates in two business segments: generic pharmaceuticals and proprietary pharmaceuticals. Barr’s generic product portfolio includes solid oral dosage forms, injectables, liquids and cream/ointment products. It markets and sells generic pharmaceutical products in the United States, Europe and certain other countries in the rest of the world (ROW). The Company’s proprietary product portfolio and pipeline is largely concentrated in the area of female healthcare. It markets and sells p(Source: 10-K)